共 14 条
- [1] Donadio, Glassock, Immunosuppressive drug therapy in lupus nephritis, Am J Kidney Dis, 21, pp. 239-250, (1993)
- [2] Ginzler, Diamond, Kaplan, Weiner, Schlesinger, Seleznick, Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus, Arthritis Rheum, 21, pp. 37-44, (1978)
- [3] Esdaile, Levinton, Federgreen, Hayslett, Kashgarian, The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: A study of 87 patients and review of the literature, Q J Med, 72, pp. 779-833, (1989)
- [4] Liang, Socher, Larson, Schur, Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus, Arthritis Rheum, 32, (1989)
- [5] Vitali, Bencivelli, Isenberg, Smolen, Snaith, Sciuto, Neri, Bombardieri, Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score, Clin Exp Rheumatol, 10, pp. 541-547, (1992)
- [6] Bombardier, Gladman, Urowitz, Caron, Chang, Derivation of the SLEDAI, A disease activity index for lupus patients, 35, pp. 630-639, (1992)
- [7] Lewis, Hunsicker, Lan, Rohde, Lachin, A controlled trial of plasmapheresis therapy in severe lupus nephritis, N Engl J Med, 326, pp. 1373-1379, (1992)
- [8] Ricker, Hebert, Rohde, Sedmak, Lewis, Clough, Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels, Am J Kidney Dis, 18, pp. 678-685, (1991)
- [9] Kohler, Wandel, Brunck, Acanthocyturia—A characteristic marker for glomerular bleeding, Kidney Int, 40, pp. 115-120, (1991)
- [10] Fairley, Birch, Microscopic urinalysis in glomerulonephritis, Kidney Int, 44, (1993)